Giuseppe La Tona

Prof. Giuseppe La Tona


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2021 in Journal of Imaging
Verified
Journal Article
Open access
PDF file
GCGiuseppe Cutaia
Giuseppe Cutaia
GTGiuseppe La Tona
Giuseppe La Tona
Albert ComelliAlbert Comelli
Albert Comelli
Federica VernuccioFederica Vernuccio
Federica Vernuccio
FAFrancesco Agnello
Francesco Agnello
Giuseppe SalvaggioGiuseppe Salvaggio
Giuseppe Salvaggio
Multiparametric prostate magnetic resonance imaging (mpMRI) is widely used as a triage test for men at a risk of prostate cancer. However, the traditional role of mpMRI was confined to prostate cancer staging. Radiomics is the quantitative extraction and analysis of minable data from medical images; it is emerging as a promising tool to detect and categorize prostate lesions. In this paper we review the role of radiomics applied to prostate mpMRI in detection and localization of prostate cancer, prediction of Gleason score and PI-RADS classification, prediction of extracapsular extension and of biochemical recurrence. We also provide a future perspective of artificial intelligence (machine learning and deep learning) applied to the field of prostate cancer.

9 June 2021 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Paola FeracoPaola Feraco
Paola Feraco
Cesare GagliardoCesare Gagliardo
Cesare Gagliardo
GTGiuseppe La Tona
Giuseppe La Tona
EBEleonora Bruno
Eleonora Bruno
CDCostanza D’angelo
Costanza D’angelo
Roberto MonasteroRoberto Monastero
Roberto Monastero
Parkinson’s disease (PD) is a progressive neurodegenerative disorder, characterized by motor and non-motor symptoms due to the degeneration of the pars compacta of the substantia nigra (SNc) with dopaminergic denervation of the striatum. Although the diagnosis of PD is principally based on a clinical assessment, great efforts have been expended over the past two decades to evaluate reliable biomarkers for PD. Among these biomarkers, magnetic resonance imaging (MRI)-based biomarkers may play a key role. Conventional MRI sequences are considered by many in the field to have low sensitivity, while advanced pulse sequences and ultra-high-field MRI techniques have brought many advantages, particularly regarding the study of brainstem and subcortical structures. Nowadays, nigrosome imaging, neuromelanine-sensitive sequences, iron-sensitive sequences, and advanced diffusion weighted imaging techniques afford new insights to the non-invasive study of the SNc. The use of these imaging methods, alone or in combination, may also help to discriminate PD patients from control patients, in addition to discriminating atypical parkinsonian syndromes (PS). A total of 92 articles were identified from an extensive review of the literature on PubMed in order to ascertain the-state-of-the-art of MRI techniques, as applied to the study of SNc in PD patients, as well as their potential future applications as imaging biomarkers of disease. Whilst none of these MRI-imaging biomarkers could be successfully validated for routine clinical practice, in achieving high levels of accuracy and reproducibility in the diagnosis of PD, a multimodal MRI-PD protocol may assist neuroradiologists and clinicians in the early and differential diagnosis of a wide spectrum of neurodegenerative disorders.

6 December 2021 in Neurology International
Verified
Journal Article
Open access
PDF file
APAntonia Pignolo
Antonia Pignolo
MAMaria Aprile
Maria Aprile
Cesare GagliardoCesare Gagliardo
Cesare Gagliardo
Giovanni M. GiammancoGiovanni M. Giammanco
Giovanni M. Giammanco
MDMarco D'Amelio
Marco D'Amelio
Paolo RagonesePaolo Ragonese
Paolo Ragonese
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been associated with several neurological disorders including headache, facial palsy, encephalitis, stroke, demyelinating disorders. The present report will discuss cases of multiple sclerosis (MS) onset and relapse both beginning early after SARS-CoV-2 infection. In both cases, magnetic resonance imaging (MRI) showed widespread bilateral subcortical and periventricular active lesions. Serum IgG against SARS-CoV-2 Spike antigens confirmed seroconversion with titers that are considered not definitely protective against possible reinfection. We hypothesize that SARS-CoV-2 infection, as previously reported for other viruses, could drive an active inflammatory response that can contribute either to the onset of MS or its relapse. The presented data further support the importance of vaccination in individuals with MS.

4 January 2021 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Cesare GagliardoCesare Gagliardo
Cesare Gagliardo
Roberto CannellaRoberto Cannella
Roberto Cannella
CDCostanza D’angelo
Costanza D’angelo
PTPatrizia Toia
Patrizia Toia
Giuseppe SalvaggioGiuseppe Salvaggio
Giuseppe Salvaggio
MMMassimo Midiri
Massimo Midiri
Background: High-quality intraoperative imaging is needed for optimal monitoring of patients undergoing transcranial MR-guided Focused Ultrasound (tcMRgFUS) thalamotomy. In this paper, we compare the intraoperative imaging obtained with dedicated FUS-Head coil and standard body radiofrequency coil in tcMRgFUS thalamotomy using 1.5-T MR scanner. Methods: This prospective study included adult patients undergoing tcMRgFUS for treatment of essential tremor. Intraoperative T2-weighted FRFSE sequences were acquired after the last high-energy sonication using a dedicated two-channel FUS-Head (2ch-FUS) coil and body radiofrequency (body-RF) coil. Postoperative follow-ups were performed at 48 h using an eight-channel phased-array (8ch-HEAD) coil. Two readers independently assessed the signal-to-noise ratio (SNR) and evaluated the presence of concentric lesional zones (zone I, II and III). Intraindividual differences in SNR and lesional findings were compared using the Wilcoxon signed rank sum test and McNemar test. Results: Eight patients underwent tcMRgFUS thalamotomy. Intraoperative T2-weighted FRFSE images acquired using the 2ch-FUS coil demonstrated significantly higher SNR (R1 median SNR: 10.54; R2: 9.52) compared to the body-RF coil (R1: 2.96, p < 0.001; R2: 2.99, p < 0.001). The SNR was lower compared to the 48-h follow-up (p < 0.001 for both readers). Intraoperative zone I and zone II were more commonly visualized using the 2ch-FUS coil (R1, p = 0.031 and p = 0.008, R2, p = 0.016, p = 0.008), without significant differences with 48-h follow-up (p ≥ 0.063). The inter-reader agreement was almost perfect for both SNR (ICC: 0.85) and lesional findings (k: 0.82–0.91). Conclusions: In the study population, the dedicated 2ch-FUS coil significantly improved the SNR and visualization of lesional zones on intraoperative imaging during tcMRgFUS performed with a 1.5-T MR scanner.

13 November 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Carmela BalistreriCarmela Balistreri
Carmela Balistreri
GTGiuseppe La Tona
Giuseppe La Tona
AMAurora Meli
Aurora Meli
Filippo BrighinaFilippo Brighina
Filippo Brighina
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencepha-lopathy (CADASIL) is the prototypical monogenic cerebral small vessel disease caused by pathogenic variants in NOTCH3. Despite its well-established genetic basis, CADASIL ex-hibits substantial clinical, radiological, and biological heterogeneity, indicating that dis-ease expression is shaped by interactions between the causal variant and additional ge-netic, epigenetic, sex-related, and environmental modifiers. This review provides an inte-grative overview of CADASIL pathogenesis, from NOTCH3 structure and signaling ab-normalities to vascular dysfunction and cerebral injury. We examine genotype–phenotype relationships, including the effects of variant location and non-canonical variants, and discuss the potential contribution of modifier loci, vascular risk factors, and sex-specific mechanisms. Emerging evidence implicates vascular smooth muscle cell dysfunction, endoplasmic reticulum and oxidative stress, inflammation, complement activation, ex-tracellular-matrix remodeling, and alterations of the neurovascular unit in disease pro-gression. We further evaluate genetic, structural, physiological, and molecular biomarkers, highlighting the potential of multimodal approaches to characterize disease burden, iden-tify early vascular dysfunction, and improve patient stratification. Finally, we discuss current supportive and preventive management alongside emerging therapeutic strategies targeting NOTCH3 production and processing, extracellular protein accumulation, vas-cular-cell dysfunction, and downstream pathological pathways. Although precision medicine in CADASIL remains primarily focused on integrated diagnosis and phenotyp-ing, advances in patient-specific models, biomarker development, and mecha-nism-informed interventions provide a framework for future therapeutic development. A better understanding of disease modifiers and pathogenic pathways will be essential to improve prognostic assessment and advance individualized management.